Protara Therapeutics, Inc. (TARA)
2.70
-0.06
(-2.17%)
USD |
NASDAQ |
Oct 02, 16:00
2.695
0.00 (0.00%)
After-Hours: 20:00
Protara Therapeutics Price : 2.70 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 2.81 | 2.95 | 2.62 | 2.70 | 1.909M |
| Oct 01, 2026 | 3.06 | 3.10 | 2.745 | 2.76 | 4.999M |
| Sep 30, 2026 | 3.23 | 3.30 | 2.98 | 3.05 | 8.825M |
| Sep 29, 2026 | 3.33 | 3.345 | 3.21 | 3.21 | 391465.0 |
| Sep 28, 2026 | 3.27 | 3.386 | 3.19 | 3.25 | 431134.0 |
| Sep 25, 2026 | 3.35 | 3.44 | 3.23 | 3.28 | 552943.0 |
| Sep 24, 2026 | 3.54 | 3.55 | 3.315 | 3.35 | 661971.0 |
| Sep 23, 2026 | 3.69 | 3.75 | 3.44 | 3.54 | 882844.0 |
| Sep 22, 2026 | 3.55 | 3.88 | 3.55 | 3.68 | 2.893M |
| Sep 21, 2026 | 3.59 | 3.68 | 3.47 | 3.51 | 735465.0 |
| Sep 18, 2026 | 3.69 | 3.725 | 3.45 | 3.55 | 3.946M |
| Sep 17, 2026 | 3.65 | 3.76 | 3.62 | 3.70 | 654157.0 |
| Sep 16, 2026 | 3.78 | 3.87 | 3.615 | 3.62 | 2.061M |
| Sep 15, 2026 | 3.91 | 3.94 | 3.74 | 3.75 | 901081.0 |
| Sep 14, 2026 | 3.83 | 4.015 | 3.818 | 3.91 | 735185.0 |
| Sep 11, 2026 | 3.83 | 3.95 | 3.81 | 3.82 | 532026.0 |
| Sep 10, 2026 | 3.83 | 3.83 | 3.735 | 3.79 | 467373.0 |
| Sep 09, 2026 | 3.86 | 3.945 | 3.83 | 3.83 | 287160.0 |
| Sep 08, 2026 | 3.92 | 3.955 | 3.83 | 3.89 | 385700.0 |
| Sep 04, 2026 | 3.93 | 3.96 | 3.89 | 3.94 | 203007.0 |
| Sep 03, 2026 | 3.94 | 3.98 | 3.87 | 3.97 | 239457.0 |
| Sep 02, 2026 | 3.92 | 4.000 | 3.855 | 3.94 | 335411.0 |
| Sep 01, 2026 | 3.81 | 3.915 | 3.795 | 3.90 | 222411.0 |
| Aug 31, 2026 | 3.79 | 3.88 | 3.72 | 3.86 | 506469.0 |
| Aug 28, 2026 | 3.99 | 3.99 | 3.785 | 3.82 | 399079.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| NovelStem International Corp. | 0.0095 |
| Brainstorm Cell Therapeutics, Inc. | 0.9302 |
| Summit Therapeutics, Inc. | 16.76 |
| Kezar Life Sciences, Inc. | 7.29 |
| Clene, Inc. | 4.08 |
Price Related Metrics
| Price to Book Value | 0.9889 |
| Earnings Yield | -50.14% |
| Market Cap | 159.53M |